Tags |
|
|
Links |
|
|
E-Articles - Gastric Bypass – Choosing the Right Obesity Clinic Can Reduce Your Risk
Gastric bypass surgery can be a lifesaver for the morbidly obese, but any operation can be risky. Since high blood pressure and diabetes are common conditions for overweight patients, surgery
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
can be even more risky than normal.
A recent University of Washington study looked at the outcomes of Medicaid patients between the ages of 35 to 44 who had obesity surgery. 5% of the men a
A recent University of Washington study looked at the outcomes of Medicaid patients between the ages of 35 to 44 who had obesity surgery. 5% of the men a
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
nd almost 3% of the women in this age group died within a year of the surgery.
Astonishingly, among Medicaid patients from 65 to 74 years old, almost 13% of the men and 6% of the women died
Astonishingly, among Medicaid patients from 65 to 74 years old, almost 13% of the men and 6% of the women died
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ithin a year of surgery, and for patients over 74 the risk of dying was 50% for men, 40% for women.
These statistics are considerably higher than previously thought. Since some complications
These statistics are considerably higher than previously thought. Since some complications
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
from gastric bypass surgery can be fatal, it’s important to know if an obesity center's experience with gastric bypass surgeries has an effect on the number of complications and risk.
To fi
To fi
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
nd out, a research study was carried out at Tufts-New England Medical Center. Their findings gave startling results. All of the patients in the study, a total of 750, had a common form of gas
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ric bypass surgery called the laparoscopic Roux-en-Y.
The surgeries were performed between March 1998 and April 2004, at the Tufts-New England Medical Center obesity center.
Researchers com
The surgeries were performed between March 1998 and April 2004, at the Tufts-New England Medical Center obesity center.
Researchers com
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
bed through the records of these patients, looking at outcomes of the surgery. This study looked at the records of the first 100 laparoscopic Roux-en-Y surgeries performed in their center, an
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
d compared them to the results of the next 650 surgeries that were performed later, after the clinic had more experience with this type of procedure.
Among the patient records that were revi
Among the patient records that were revi
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
wed, it was found that the first 100 gastric bypass surgeries had 26 major complications, including one death. The percentage of patients with complications for the other group went down to 1
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
3%, and only two patients out of 650 died as a result of the procedure.
The number of wound infections went down from 8% in the first 100 patients, to 2% in the other group. There were no bo
The number of wound infections went down from 8% in the first 100 patients, to 2% in the other group. There were no bo
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
wl obstructions in the second group, while 5% of the first 100 patients had this serious complication from their surgery.
The amount of time a patient stayed on the operating table was also
The amount of time a patient stayed on the operating table was also
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ignificant, dropping by over a third:
• First 100 patients spent an average of 212 minutes in the operating room.
• The 650 patents in the second group spent an average of 132 minutes in th
• First 100 patients spent an average of 212 minutes in the operating room.
• The 650 patents in the second group spent an average of 132 minutes in th
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
e operating room.
It is interesting to note that this study looked at the outcomes of all patients in one obesity center. Even though some doctors came and went during the length of the stud
It is interesting to note that this study looked at the outcomes of all patients in one obesity center. Even though some doctors came and went during the length of the stud
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
y, the total experience in the clinic as a whole made a significant difference in the patient’s outcomes.
Another study, headed by Dr. David Flum of the University of Washington, found that
Another study, headed by Dr. David Flum of the University of Washington, found that
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
astric bypass operations performed by some hospitals in that state had many more major complications and deaths than those performed in other centers.
At one Washington hospital, more than 4
At one Washington hospital, more than 4
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
% of the patients died from obesity surgery. The results of the study were so startling that the state’s Department of Social and Health Services stopped paying for the procedure for one year
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
.
They now cover the operation again, but will pay for the surgeries only if they are performed in a Center of Excellence, and patients must meet specific guidelines to be eligible. Many maj
They now cover the operation again, but will pay for the surgeries only if they are performed in a Center of Excellence, and patients must meet specific guidelines to be eligible. Many maj
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
r insurance carriers have also adopted these guidelines, so their members will have the best possible chance of good outcomes from gastric bypass surgery.
To reduce your chances of suffering
To reduce your chances of suffering
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
from major complications after gastric bypass surgery, it makes sense to find out if your obesity center is designated as a fully approved ASBS Bariatric Surgery Center of Excellence (BSCOE)
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/261678/e-article-Gastric-Bypass--Choosing-the-Right-Obesity-Clinic-Can-Reduce-Your-Risk.html">Gastric Bypass – Choosing the Right Obesity Clinic Can Reduce Your Risk</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/261678/e-article-Gastric-Bypass--Choosing-the-Right-Obesity-Clinic-Can-Reduce-Your-Risk.html]Gastric Bypass – Choosing the Right Obesity Clinic Can Reduce Your Risk[/url]
Related Articles:
Direct Mail Marketing With Postcards: The Headline Factor
Incline Village Lake Tahoe Real Estate Market
Bookmark it:
|